Profound Medical Corp. (PROF)
Stock analysis · NASDAQ · Healthcare · Medical - Devices
Profound Medical Corp. (PROF) is a publicly traded company in the Healthcare sector. Latest price: $5.65. Market cap $206.23M. Trailing PE -5.78. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 16 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Earnings
Proprietary Signals
About Profound Medical Corp.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Valuation
| P/E (TTM) | -5.78× |
|---|---|
| P/S (TTM) | 10.80× |
| P/B | 4.10× |
| P/FCF (TTM) | -5.72× |
| EV / EBITDA | -5.20× |
| EV / Sales | 9.17× |
| Earnings Yield | -15.91% |
| Free Cash Flow Yield | -17.48% |
Fundamentals
| Enterprise Value | $173.95M |
|---|---|
| Revenue (TTM) | $18.97M |
| Net Income (TTM) | -$32.58M |
| Free Cash Flow (TTM) | -$35.86M |
| Net Debt | -$30.84M |
| Working Capital | $49.67M |
| Gross Margin | 71.73% |
| Operating Margin | -184.35% |
| Net Margin | -170.92% |
| Return on Equity | -62.45% |
| Return on Invested Capital | -60.49% |
Peers
Recent News
- Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let's Huddle' Webinar
- Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect?
- TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion O…
- Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?
- Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
Related
Browse more tickers: sitemap